Prescriptions: Botox for Migraines Is Approved
Friday, October 15, 2010 - 18:40
in Mathematics & Economics
The Food and Drug Administration’s decision to give Allergan the go-ahead to market Botox for chronic migraines comes after the company paid $600 million to settle illegal marketing allegations.